Skip to content

Codiak BioSciences, Inc.

CIK 0001659352

← back to feed
Revenue (TTM)
$27.9M
+686.8% YoY Q3 Oct 2022
Net Income (TTM)
−$55.78M
+59.5% YoY Q3 Oct 2022
EPS Diluted (TTM)
—
Q3 Oct 2022
Gross Margin
—
Q3 Oct 2022
Operating Margin
-208.5%
Q3 Oct 2022
Net Margin
-200.0%
Q3 Oct 2022
Free Cash Flow (TTM)
−$77.39M
Q3 Oct 2022
Cash
$51.76M
Q3 Oct 2022
Total Debt
—
Q3 Oct 2022
Shares Outstanding
36.83M sh
Q3 Oct 2022

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings